✦ LIBER ✦

Risk assessment for cancer-associated thrombosis: What is the best approach?

✍ Scribed by Alok A. Khorana

Book ID: 117258489
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 218 KB
Volume: 129
Category: Article
ISSN: 0049-3848
DOI: 10.1016/s0049-3848(12)70009-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What is the best way to treat high-risk

What is the best way to treat high-risk prostate cancer?

✍ Eric A. Klein 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract No abtract.

What is the best approach for breast con

What is the best approach for breast conserving therapy?

✍ Tomohiko Okawa; Goi Sakamoto 📂 Article 📅 1998 🏛 Springer Japan 🌐 English ⚖ 85 KB

What is the best approach for screen-det

What is the best approach for screen-detected low volume cancers?—The case for observation

✍ Laurence Klotz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

What Is the Best Treatment for Stage IV

What Is the Best Treatment for Stage IV Colorectal Cancer?

✍ Alfred M. Cohen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 48 KB

Individual Risk Assessment Is the Best S

Individual Risk Assessment Is the Best Strategy for Thromboembolic Prophylaxis

✍ Joseph A. Caprini 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Management of cancer-associated thrombot

Management of cancer-associated thrombotic microangiopathy: What is the right approach?

✍ Theresa L. Werner; Neeraj Agarwal; Heather M. Carney; George M. Rodgers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

## Abstract A 49‐year‐old Caucasian woman presented with features suggestive of thrombotic microangiopathy (TMA). She did not respond to treatment with repeated plasma exchange and corticosteroids. A bone marrow biopsy revealed presence of metastatic carcinoma. A limited autopsy revealed presence o